Sandbox:Preeti
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Pathophysiology | Symptoms | Physical Examination | Laboratory Findings | ||||
---|---|---|---|---|---|---|---|
Immunochemistry | Blood work | Biospy | |||||
Diffuse large B-cell lymphoma][1][2][3][4][5][6][7] | Classified into 2 subtypes based on gene expression profiles:
|
|
|
|
|
Centroblastic
Immunoblastic::
Anaplastic:
| |
Follicular lymphoma |
|
|
|||||
Burkitt lymphoma |
|
|
|
| |||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
|
CBC
|
|
Nodal marginal zone B-cell lymphoma |
|
|
|
| |||
Splenic marginal zone lymphoma |
|
| |||||
Hairy cell leukemia |
|
|
| ||||
Plasma cell myeloma | |||||||
Chronic lymphocytic leukemia / small lymphocytic lymphoma | |||||||
Monoclonal B-cell lymphocytosis | |||||||
B-cell prolymphocytic leukemia | |||||||
Waldenström's macroglubulinemia | |||||||
Monoclonal gammopathy of undetermined significance (MGUS) | |||||||
Heavy chain disease | |||||||
Solitary plasmacytoma of bone | |||||||
Extraosseous plasmacytoma | |||||||
Monoclonal immunoglobulin deposition diseases | |||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | |||||||
Large B-cell lymphoma with IRF4 rearrangement | |||||||
Primary cutaneous follicle center lymphoma | |||||||
T-cell/histiocyte-rich large B-cell lymphoma | |||||||
Lymphomatoid granulomatosis | |||||||
Primary mediastinal (thymic) large B-cell lymphoma | |||||||
Intravascular large B-cell lymphoma | |||||||
ALK1 large B-cell lymphoma | |||||||
Plasmablastic lymphoma | |||||||
Primary effusion lymphoma | |||||||
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | |||||||
T cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||
T-cell granular lymphocytic leukemia |
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following: |
|
|
| ||
Subcutaneous panniculitis-like T-cell lymphoma |
- ↑ Shipp, Margaret A.; Ross, Ken N.; Tamayo, Pablo; Weng, Andrew P.; Kutok, Jeffery L.; Aguiar, Ricardo C.T.; Gaasenbeek, Michelle; Angelo, Michael; Reich, Michael; Pinkus, Geraldine S.; Ray, Tane S.; Koval, Margaret A.; Last, Kim W.; Norton, Andrew; Lister, T. Andrew; Mesirov, Jill; Neuberg, Donna S.; Lander, Eric S.; Aster, Jon C.; Golub, Todd R. (2002). "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning". Nature Medicine. 8 (1): 68–74. doi:10.1038/nm0102-68. PMID 11786909.
- ↑ Rosenwald, Andreas; Wright, George; Chan, Wing C.; Connors, Joseph M.; Campo, Elias; Fisher, Richard I.; Gascoyne, Randy D.; Muller-Hermelink, H. Konrad; Smeland, Erlend B.; Giltnane, Jena M.; Hurt, Elaine M.; Zhao, Hong; Averett, Lauren; Yang, Liming; Wilson, Wyndham H.; Jaffe, Elaine S.; Simon, Richard; Klausner, Richard D.; Powell, John; Duffey, Patricia L.; Longo, Dan L.; Greiner, Timothy C.; Weisenburger, Dennis D.; Sanger, Warren G.; Dave, Bhavana J.; Lynch, James C.; Vose, Julie; Armitage, James O.; Montserrat, Emilio; et al. (2002). "The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma". New England Journal of Medicine. 346 (25): 1937–47. doi:10.1056/NEJMoa012914. PMID 12075054.
- ↑ Colomo, L.; López-Guillermo, A; Perales, M; Rives, S; Martínez, A; Bosch, F; Colomer, D; Falini, B; Montserrat, E; Campo, E (2002). "Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma". Blood. 101 (1): 78–84. doi:10.1182/blood-2002-04-1286. PMID 12393466.
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov
- ↑ Tilly H, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2015; 26: v116-v125
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov
- ↑ Korkolopoulou P, Vassilakopoulos T, Milionis V, Ioannou M (2016). "Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review". Adv Anat Pathol. 23 (4): 202–43. doi:10.1097/PAP.0000000000000117. PMID 27271843.